Stifel Maintains Buy on ClearPoint Neuro, Lowers Price Target to $18
Benzinga Newsdesk 2 days ago
Analyst RatingsNewsPrice Target
Stifel analyst Mathew Blackman maintains ClearPoint Neuro (NASDAQ:CLPT) with a Buy and lowers the price target from $22 to $18.
Stifel analyst Mathew Blackman maintains ClearPoint Neuro (NASDAQ:CLPT) with a Buy and lowers the price target from $22 to $18.